Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T50594 | Target Info | |||
Target Name | Serine/threonine-protein kinase pim-1 (PIM1) | ||||
Synonyms | Pim-1 proto-oncogene, serine/threonine kinase; PIM | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PIM1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Quercetin | Ligand Info | |||
Canonical SMILES | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O | ||||
InChI | 1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H | ||||
InChIKey | REFJWTPEDVJJIY-UHFFFAOYSA-N | ||||
PubChem Compound ID | 5280343 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4LMU Crystal structure of Pim1 in complex with the inhibitor Quercetin (resulting from displacement of SKF86002) | ||||||
Method | X-ray diffraction | Resolution | 2.38 Å | Mutation | No | [1] |
PDB Sequence |
SQYQVGPLLG
45 SGGFGSVYSG55 IRVSDNLPVA65 IKHVEKDRIS75 DWGETRVPME89 VVLLKKVSSG 99 FSGVIRLLDW109 FERPDSFVLI119 LERPEPVQDL129 FDFITERGAL139 QEELARSFFW 149 QVLEAVRHCH159 NCGVLHRDIK169 DENILIDLNR179 GELKLIDFGS189 GALLKDTVYT 199 DFDGTRVYSP209 PEWIRYHRYH219 GRSAAVWSLG229 ILLYDMVCGD239 IPFEHDEEII 249 RGQVFFRQRV259 SSECQHLIRW269 CLALRPSDRP279 TFEEIQNHPW289 MQDVLLPQET 299 AEIHL
|
|||||
|
||||||
PDB ID: 2O3P Crystal structure of Pim1 with Quercetin | ||||||
Method | X-ray diffraction | Resolution | 2.24 Å | Mutation | No | [2] |
PDB Sequence |
PLESQYQVGP
42 LLGSGGFGSV52 YSGIRVSDNL62 PVAIKHVEKD72 RISDWGELPN82 GTRVPMEVVL 92 LKKVSSGFSG102 VIRLLDWFER112 PDSFVLILER122 PEPVQDLFDF132 ITERGALQEE 142 LARSFFWQVL152 EAVRHCHNCG162 VLHRDIKDEN172 ILIDLNRGEL182 KLIDFGSGAL 192 LKDTVYTDFD202 GTRVYSPPEW212 IRYHRYHGRS222 AAVWSLGILL232 YDMVCGDIPF 242 EHDEEIIRGQ252 VFFRQRVSSE262 CQHLIRWCLA272 LRPSDRPTFE282 EIQNHPWMQD 292 VLLPQETAEI302 HLHS
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002. Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):392-404. | ||||
REF 2 | Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther. 2007 Jan;6(1):163-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.